| Activation of STING-dependent innate immune signaling by S-phase-specific DNA damage in breast cancer EE Parkes, SM Walker, LE Taggart, N McCabe, LA Knight, R Wilkinson, ... Journal of the National Cancer Institute 109 (1), djw199, 2017 | 428 | 2017 |
| BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer JJ Gorski, CR James, JE Quinn, GE Stewart, KC Staunton, NE Buckley, ... Breast cancer research and treatment 122, 721-731, 2010 | 145 | 2010 |
| BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers D Tkocz, NT Crawford, NE Buckley, FB Berry, RD Kennedy, JJ Gorski, ... Oncogene 31 (32), 3667-3678, 2012 | 108 | 2012 |
| T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells KL Redmond, NT Crawford, H Farmer, ZC D'costa, GJ O'brien, ... Oncogene 29 (22), 3252-3262, 2010 | 95 | 2010 |
| The 2, 5 oligoadenylate synthetase/RNaseL pathway is a novel effector of BRCA1-and interferon-γ-mediated apoptosis PB Mullan, AM Hosey, NE Buckley, JE Quinn, RD Kennedy, PG Johnston, ... Oncogene 24 (35), 5492-5501, 2005 | 78 | 2005 |
| S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability NE Buckley, Z D'costa, M Kaminska, PB Mullan Cell death & disease 5 (2), e1070-e1070, 2014 | 72 | 2014 |
| Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment NE Buckley, C Forde, DG McArt, DP Boyle, PB Mullan, JA James, ... Scientific reports 6 (1), 23383, 2016 | 58 | 2016 |
| BRCA1 regulates IFN-γ signaling through a mechanism involving the type I IFNs NE Buckley, AM Hosey, JJ Gorski, JW Purcell, JM Mulligan, DP Harkin, ... Molecular cancer research 5 (3), 261-270, 2007 | 55 | 2007 |
| Automated tumour recognition and digital pathology scoring unravels new role for PD‐L1 in predicting good outcome in ER‐/HER2+ breast cancer MP Humphries, S Hynes, V Bingham, D Cougot, J James, F Patel-Socha, ... Journal of Oncology 2018 (1), 2937012, 2018 | 53 | 2018 |
| Dual mechanisms of LYN kinase dysregulation drive aggressive behavior in breast cancer cells G Tornillo, C Knowlson, H Kendrick, J Cooke, H Mirza, ... Cell reports 25 (13), 3674-3692. e10, 2018 | 52 | 2018 |
| BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers NE Buckley, CB Nic An tSaoir, JK Blayney, LC Oram, NT Crawford, ... Nucleic acids research 41 (18), 8601-8614, 2013 | 50 | 2013 |
| TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities. ZC D'Costa, C Higgins, CW Ong, GW Irwin, D Boyle, DG McArt, ... Oncotarget 5 (6), 1609, 2014 | 48 | 2014 |
| The ΔNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer NE Buckley, SJ Conlon, K Jirstrom, EW Kay, NT Crawford, A O'Grady, ... Cancer research 71 (5), 1933-1944, 2011 | 48 | 2011 |
| Rational design and characterisation of a linear cell penetrating peptide for non-viral gene delivery EM McErlean, M Ziminska, CM McCrudden, JW McBride, SP Loughran, ... Journal of Controlled Release 330, 1288-1299, 2021 | 47 | 2021 |
| TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells NT Crawford, AJ McIntyre, A McCormick, ZC D’Costa, NE Buckley, ... Oncogene 38 (31), 5971-5986, 2019 | 45 | 2019 |
| BRCA1–conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer NE Buckley, PB Mullan Stem Cell Reviews and Reports 8, 982-993, 2012 | 45 | 2012 |
| A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer NE Buckley, P Haddock, RDM Simoes, E Parkes, G Irwin, F Emmert-Streib, ... Oncotarget 7 (15), 19884, 2016 | 36 | 2016 |
| The clinical and molecular significance associated with STING signaling in breast cancer EE Parkes, MP Humphries, E Gilmore, FA Sidi, V Bingham, SM Phyu, ... NPJ Breast Cancer 7 (1), 81, 2021 | 25 | 2021 |
| Long-term outcomes of treatment of hyperthyroidism in Ireland AC Leary, G Grealy, TM Higgins, N Buckley, DG Barry, D Murphy, ... Irish journal of medical science 168, 47-52, 1999 | 25 | 1999 |
| Exploring the potential of microRNA Let-7c as a therapeutic for prostate cancer EJ Mulholland, WP Green, NE Buckley, HO McCarthy Molecular Therapy-Nucleic Acids 18, 927-937, 2019 | 24 | 2019 |
D Paul HarkinProfessor of Molecular Oncology Queens University Belfast在 qub.ac.uk 的电子邮件经过验证
